Estradiol, the primary female sex hormone, modulates immune function and thus allergic responses. It binds to estrogen receptors on immune cells such as mast cells, eosinophils, and T helper cells. Research indicates a dual role: estradiol can enhance histamine release from mast cells and increase IgE production, potentially amplifying allergic inflammation. Conversely, it may also exert anti-inflammatory effects depending on concentration, receptor subtype (ERα vs. ERβ), and tissue context. Clinically, allergies are more prevalent in women after puberty, and hormonal fluctuations during pregnancy or hormone therapy can alter allergy severity. The evidence base is largely mechanistic (cell and animal studies) and observational (human cohort studies); no robust RCTs directly test estradiol modulation for allergy treatment. MyBody-X does not currently offer estradiol-related genetic or biomarker tests for allergy. Any interpretation of estradiol's role in allergies must consider the complex interplay of genetics, environment, and hormonal status. Testing estradiol alone is not diagnostic or predictive for allergies.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-58c766e536cc07c3eb5d879d